jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Anti Nuclear Antibodies (ANA)

Immunity
image

Report in 4Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Antinuclear antibody test screens for autoimmune diseases such as lupus or Sjögren’s syndrome.

265750

65% OFF

Anti-Nuclear Antibodies (ANA) Test Information Guide

  • Why is it done?
    • Detects autoimmune antibodies directed against nuclear antigens within cells, helping identify autoimmune and connective tissue disorders
    • Screens for systemic lupus erythematosus (SLE) and other autoimmune diseases when patients present with joint pain, rashes, fever, or fatigue
    • Evaluates symptoms suggestive of autoimmune connective tissue disease including Sjögren's syndrome, scleroderma, and mixed connective tissue disease
    • Monitors disease activity and treatment response in patients with diagnosed autoimmune conditions
    • Typically performed during initial evaluation of unexplained systemic symptoms or when autoimmune disease is clinically suspected
  • Normal Range
    • Negative or Titer <1:40 (or <1:80 depending on laboratory standards) - considered normal
    • Results reported as either negative/positive or as titers (1:40, 1:80, 1:160, 1:320, 1:640, 1:1280, or higher)
    • Unit of measurement: Titer (dilution ratio) or qualitative positive/negative result
    • Normal result (negative) indicates absence of significant autoimmune activity against nuclear antigens
    • Abnormal result (positive) suggests presence of autoimmune disease or autoimmune tendency and requires further investigation
    • Low positive titers (1:40-1:80) may have lower clinical significance; moderate to high titers (≥1:160) more strongly correlate with disease
  • Interpretation
    • Negative ANA: Usually excludes active SLE and most connective tissue diseases; however, does not completely rule out these conditions in all cases
    • Positive ANA at 1:40-1:80 (low titer): May be seen in healthy individuals, chronic infections, or mild autoimmune conditions; clinical correlation essential
    • Positive ANA at 1:160-1:320 (moderate titer): Significant finding; strongly suggestive of autoimmune disease when accompanied by compatible clinical symptoms
    • Positive ANA at ≥1:640 (high titer): Highly suggestive of autoimmune disease; stronger predictor of SLE and related conditions
    • Pattern interpretation: Homogeneous pattern (common in SLE), speckled pattern (associated with Sjögren's, mixed connective tissue disease), nucleolar pattern (seen in scleroderma), and peripheral/rim pattern (highly specific for SLE)
    • Factors affecting results: Age (higher prevalence in elderly), medications (hydralazine, procainamide, quinidine), infections, malignancy, and smoking status may influence results
    • Clinical correlation is essential; positive ANA must be evaluated with patient symptoms, other laboratory findings (complement levels, ESR, CRP), and imaging results for accurate diagnosis
    • Persistence of positive ANA over time may indicate chronic autoimmune disease; changing titers may correlate with disease activity in some conditions
  • Associated Organs
    • Primary organ system: Immune system (produces autoimmune antibodies); secondary involvement includes connective tissues, joints, skin, and multiple organ systems
    • Systemic Lupus Erythematosus (SLE): Multisystem disease affecting joints, skin, kidneys, heart, lungs, and blood; ANA positive in 95-98% of SLE cases
    • Sjögren's Syndrome: Autoimmune disease targeting salivary and lacrimal glands; ANA positive in 50-80% of cases with associated anti-SSA/Ro and anti-SSB/La antibodies
    • Scleroderma (Systemic Sclerosis): Connective tissue disease affecting skin, lungs, heart, and kidneys; ANA positive in 95% of cases, often with anticentromere or anti-Scl-70 antibodies
    • Rheumatoid Arthritis: Joint inflammation; ANA positive in 30-50% of cases; more specific markers include rheumatoid factor and anti-CCP antibodies
    • Mixed Connective Tissue Disease (MCTD): Overlapping features of SLE, myositis, and scleroderma; ANA positive with characteristic anti-RNP antibodies
    • Potential complications: Positive ANA in SLE may indicate risk for lupus nephritis (kidney disease), serositis (pleural/pericardial inflammation), and vasculitis
    • Drug-induced lupus: Associated with medications; ANA positive but typically antihistone antibodies; usually reversible upon medication discontinuation
  • Follow-up Tests
    • ANA panel with specific antibodies: Anti-dsDNA, anti-Smith (anti-Sm), anti-SSA/Ro, anti-SSB/La, anticentromere (ACA), anti-Scl-70, and anti-RNP for disease differentiation
    • Complement levels (C3, C4): Decreased levels suggest active SLE and lupus nephritis; assessed to evaluate disease activity and severity
    • Complete blood count (CBC): Detects cytopenias (low white blood cells, platelets) common in SLE; may show anemia
    • Comprehensive metabolic panel: Assesses kidney and liver function; important in autoimmune diseases with multiorgan involvement
    • Urinalysis: Screens for lupus nephritis with proteinuria, hematuria, and RBC casts; essential in SLE monitoring
    • Inflammatory markers: Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) to assess systemic inflammation and disease activity
    • Rheumatoid factor and anti-CCP antibodies: If rheumatoid arthritis or overlap syndrome suspected
    • Imaging studies: Chest X-ray to evaluate pulmonary involvement; kidney ultrasound or biopsy if glomerulonephritis suspected
    • Coagulation studies: Assess for antiphospholipid antibodies if thrombosis or recurrent miscarriage history present
    • Monitoring frequency: Repeat ANA testing not routinely recommended for monitoring; specific antibodies (anti-dsDNA, complement levels) used instead to assess disease activity
  • Fasting Required?
    • No, fasting is not required for the ANA test
    • Patient can eat and drink normally before blood collection
    • No specific medications need to be withheld; continue all regular medications unless otherwise instructed by physician
    • Important note: Certain medications (hydralazine, procainamide, quinidine, isoniazid) may cause false-positive results; inform healthcare provider of current medications
    • Timing: Blood sample collection can be performed at any time of day; no specific time-of-day requirements
    • Patient preparation: Wear loose-fitting clothing to facilitate blood draw; remain calm and relaxed before venipuncture
    • No specific restrictions on hydration; adequate fluid intake may help with venipuncture

How our test process works!

customers
customers